Stay updated with breaking news from Christophers Lathan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results include a landmark study that involved seamless collaboration across adult and pediatric patient groups, leading to a highly diverse study population. Other coverage addresses access to novel therapies and what's coming in the pipeline, including CAR T-cell therapy with tyrosine kinase inhibitors.
A panel of experts at the American Society of Clinical Oncology Annual Meeting presented the latest research and equity considerations for chimeric antigen receptor (CAR) T-cell therapy in hematological cancers.
Those front-line workers will be joined by five Boston Marathon champions as they are driven the entire 26.2-mile course in Boston Duck Boats.